Haihong Zhu has over 25 year of technical, research and development, and marketing experience in stem cell and cell therapy industry. Haihong started her career in stem cell research at Harvard Medical School, then moved to BioTransplant Inc. She joined ThermoGenesis in 2004 and helped develop and market an automated cell processing technology for cell banking and cell-based therapies. She is currently a Director of the Board, and President & Chief Operating Officer at ThermoGenesis Holdings Inc (Nasdaq:THMO).

Ms. Zhu graduated from the Shanghai University of Science & Technology with a Bachelor’s in Biology and also studied statistics at Boston University.